Andre Michel Ilbawi, MD | |
1515 Holcombe Blvd, Houston, TX 77030-4009 | |
(713) 792-6161 | |
Not Available |
Full Name | Andre Michel Ilbawi |
---|---|
Gender | Male |
Speciality | Surgery - Surgical Oncology |
Location | 1515 Holcombe Blvd, Houston, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013164219 | NPI | - | NPPES |
320203801 (MDACC) | Medicaid | TX | |
8DT083 | Other | TX | BCBS (MDACC) |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | ML60020733 (Washington) | Secondary |
2086X0206X | Surgery - Surgical Oncology | P5820 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Andre Michel Ilbawi, MD Po Box 4439, Houston, TX 77210-4439 Ph: (713) 792-2991 | Andre Michel Ilbawi, MD 1515 Holcombe Blvd, Houston, TX 77030-4009 Ph: (713) 792-6161 |
News Archive
Ron Fouchier of Erasmus Medical Center, "[t]he Dutch scientist at the center of the controversy over recent bird flu experiments, says that his team applied for government permission today to submit a paper describing their research to a science journal," NPR's health blog "Shots" reports.
Atrial fibrillation, also known as AFib, is the most common type of irregular heartbeat, and it is associated with increased mortality. While researchers have identified a causal link between obesity and AFib, the underlying mechanism of how obesity contributes to the heart arrhythmia is still unknown.
Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has been awarded patent #US 8,262,737 B2 by the United States Patent Office that protects the Company against competitive interbody devices with a roughened surface topography, anti-expulsion edges, and access to a hollow center.
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.
› Verified 4 days ago
Mr. Yevgeny Shuhatovich, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Binz St. Suite 100, Houston, TX 77004 Phone: 713-520-1210 Fax: 713-400-8302 | |
Solange Erlyn Cox, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-2360 | |
Dr. Mayrim V. Rios Perez, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 902 Frostwood Dr Ste 265, Houston, TX 77024 Phone: 713-785-5007 Fax: 713-785-8877 | |
Dr. Amanda Anne Myers, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Dr. Gail E Burbridge Jr., M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 Binz St, Suite 1362, Houston, TX 77004 Phone: 713-523-2411 Fax: 713-796-8952 | |
John Davis, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1315 St Joseph Pkwy Ste 1004, Houston, TX 77002 Phone: 936-441-1010 | |
Dr. John Michael Duncan Jr., M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1101 Bates Ave, Ste P115, Houston, TX 77030 Phone: 832-355-4900 Fax: 832-355-3770 |